Want to join the conversation?
Pharmaceutical company $MYL said that the Renaissance business brings a complementary portfolio of about 25 branded and generic topical products, which when combined with Meda's offerings positions the company to be a leader in dermatology. Meda also positions $MYL at the top of the global respiratory and allergy markets.
$MON shares dip slightly; I wonder this is because of the environmental lawsuit filed by the Washington state against the production of PCBs.
My bet is that $FR will reach $32 in the short term. It’s time it broke the 52-week high and had its fair share of growth.
$WYNN got bruised up by China after its decision to cut withdrawal limit in Macau ATMs. Wynn Resorts shares went down by more than 11%! Well who could have guessed that right?